Key result
Chronic endurance exercise significantly decreased levels of lipid peroxidation in the thymus of rats treated with acute doxorubicin compared with paired-dose sedentary groups.
The use of prior exercise training has shown promise in minimizing doxorubicin (DOX)-induced physical impairments. The purpose of this study was to compare changes in thymus mass, thymocyte (T-cell) number, and tissue peroxidation following chronic endurance exercise and DOX treatment in the rat. The thymus mass, number of viable T-cells, and levels of malondialdehyde and 4-hydroxyalkenals (MDA+4-HAE) were compared 3 days post-injection between rats assigned to the following treatment conditions: (a) 10 weeks of endurance training, followed by a saline injection 24 hours after the last training session (TM+SAL); (b) treadmill training as above, followed by a single, bolus 10-mg/kg injection of DOX (TM+10); (c) treadmill training with 12.5 mg/kg of DOX (TM+12.5); (d) sedentary (without exercise) and a saline injection (SED+SAL); (e) sedentary with 10 mg/kg of DOX (SED+10); and (f) sedentary with 12.5 mg/kg (SED+12.5). Thymic mass and T-cell numbers significantly decreased following DOX injections. TM rats exhibited significantly less lipid peroxidation compared with paired-dose SED groups. TM+10 did not significantly differ from SED+SAL in thymic levels of lipid peroxidation. We conclude that chronic endurance exercise decreases levels of lipid peroxidation in the thymus seen with acute DOX treatment.
No takes yet. Share an insight, caveat, or question.
Quinn et al. (2015) studied Doxorubicin-induced thymic damage. Chronic endurance exercise vs. Sedentary condition was evaluated on Thymus mass, T-cell number, and tissue peroxidation (MDA+4-HAE). Chronic endurance exercise significantly decreased levels of lipid peroxidation in the thymus of rats treated with acute doxorubicin compared with paired-dose sedentary groups.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from Integrative Cancer Therapies